Inspire Medical Systems (INSP) Change in Accured Expenses (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Change in Accured Expenses data on file, last reported at -$12.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 24.47% year-over-year to -$12.3 million; the trailing twelve-month figure through Mar 2026 stood at $10.1 million (up 13.05% YoY), and the FY2025 full-year result was $6.1 million, down 52.41% from the prior year.
• Change in Accured Expenses fell to -$12.3 million in Q1 2026, from $6.6 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $13.7 million in Q4 2024 to a low of -$16.3 million in Q1 2025.
• A 5-year average of $1.5 million and a median of $4.5 million in 2022 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses sank 126.99% in 2022 and jumped 105.35% in 2023, its largest moves.
• Tracing INSP's Change in Accured Expenses over 5 years: stood at $4.9 million in 2022, then jumped by 105.35% to $10.1 million in 2023, then soared by 35.38% to $13.7 million in 2024, then sank by 51.44% to $6.6 million in 2025, then sank by 285.82% to -$12.3 million in 2026.
• Business Quant data shows INSP's Change in Accured Expenses at -$12.3 million in Q1 2026, $6.6 million in Q4 2025, and $10.8 million in Q3 2025.